Dare we hope?
A report in the July issue of Cancer Cell refers to blocking a fundamental process within cancer cells which selectively kills them whilst sparing normal cells.
Phase 1 trials are commencing at Peter MacCallum Cancer Centre in Melbourne Australia for about 40 leukaemia and lymphoma patients.
Use of the drug, CX-5461, in pre-clinical laboratory models showed the treatment was most successful at attacking those particular cancers.
There is a report in Science Daily, http://www.scienceda...07/120709133544
There is much reporting in the Australian Press,
Please let it be exciting!